Table 2 Crude association to identify risk factors (or tertile) associated with SAP in AIS patients
Statistics | OR(95% CI) | P-value | |
|---|---|---|---|
Sex (Male vs. Female) | (747vs 345) | 1.18 (0.78, 1.78) | 0.4383 |
Age (year) | 62.02 ± 12.86 | 1.04 (1.03, 1.06) | < 0.0001 |
Low | 343 (31.41%) | Ref | |
Middle | 350 (32.05%) | 1.21 (0.68, 2.15) | 0.5146 |
High | 399 (36.54%) | 2.51 (1.52, 4.15) | 0.0003 |
Length of hospital stay | 9.75 ± 5.39 | 1.08 (1.05, 1.12) | < 0.0001 |
Low | 325 (29.76%) | Ref | |
Middle | 342 (31.32%) | 1.04 (0.57, 1.89) | 0.8993 |
High | 425 (38.92%) | 2.53 (1.53, 4.20) | 0.0003 |
White blood cell | 8.45 ± 2.96 | 1.21 (1.14, 1.28) | <0.0001 |
Low | 334 (31.69%) | Ref | |
Middle | 366 (34.72%) | 1.68 (0.93, 3.06) | 0.0881 |
High | 354 (33.59%) | 3.58 (2.07, 6.21) | < 0.0001 |
Blood glucose | 8.43 ± 4.56 | 1.00 (0.96, 1.04) | 0.9221 |
Low | 352 (33.08%) | Ref | |
Middle | 355 (33.36%) | 1.46 (0.90, 2.38) | 0.1231 |
High | 357 (33.55%) | 1.16 (0.70, 1.92) | 0.5613 |
Lymphocytes | 1.60 ± 0.70 | 0.32 (0.21, 0.47) | < 0.0001 |
Low | 350 (33.21%) | Ref | |
Middle | 349 (33.11%) | 0.46 (0.29, 0.74) | 0.0013 |
High | 355 (33.68%) | 0.31 (0.18, 0.52) | < 0.0001 |
Neutrophils | 6.20 ± 2.90 | 1.24 (1.17, 1.32) | < 0.0001 |
Low | 351 (33.30%) | Ref | |
Middle | 351 (33.30%) | 1.82 (0.96, 3.42) | 0.0649 |
High | 352 (33.40%) | 4.83 (2.74, 8.53) | < 0.0001 |
TG | 1.72 ± 1.25 | 0.70 (0.54, 0.92) | 0.0099 |
Low | 336 (32.72%) | Ref | |
Middle | 346 (33.69%) | 0.66 (0.41, 1.09) | 0.1055 |
High | 345 (33.59%) | 0.59 (0.36, 0.99) | 0.0450 |
HDL-C | 1.10 ± 0.30 | 1.95 (1.00, 3.80) | 0.0493 |
Low | 326 (31.87%) | Ref | |
Middle | 348 (34.02%) | 1.00 (0.59, 1.72) | 0.9883 |
High | 349 (34.12%) | 1.42 (0.85, 2.35) | 0.1774 |
LDL-C | 3.10 ± 1.01 | 0.88 (0.72, 1.09) | 0.2534 |
Low | 340 (33.24%) | Ref | |
Middle | 342 (33.43%) | 0.40 (0.23, 0.69) | 0.0010 |
High | 341 (33.33%) | 0.68 (0.43, 1.10) | 0.1181 |
Fibrinogen | 3.12 ± 0.85 | 1.55 (1.25, 1.92) | < 0.0001 |
Low | 363 (33.24%) | Ref | |
Middle | 364 (33.33%) | 1.15 (0.68, 1.96) | 0.5977 |
High | 365 (33.42%) | 1.99 (1.22, 3.23) | 0.0055 |
TC | 4.66 ± 1.14 | 0.87 (0.72, 1.05) | 0.1517 |
Low | 342 (33.30%) | Ref | |
Middle | 342 (33.30%) | 0.53 (0.32, 0.89) | 0.0172 |
High | 343 (33.40%) | 0.65 (0.40, 1.06) | 0.0842 |
Diabetes (without vs. with) | (701 vs.391) | 0.76 (0.50, 1.16) | 0.2053 |
Hypertension (without vs. with) | (174 vs. 918) | 0.99 (0.58, 1.68) | 0.8780 |
Atrial fibrillation (without vs. with) | (1016 vs. 76) | 4.87 (2.86, 8.28) | < 0.0001 |
Venous thrombolysis (without vs. with) | (919 vs. 173) | 3.54 (2.31, 5.43) | < 0.0001 |